INVEX Therapeutics Ltd Financial Flexibility Index
INVEX Therapeutics Ltd financial flexibility index. INVEX Therapeutics Ltd (IXC) has a Financial Flexibility Index of -4.42x as of December 2025. Free cash flow of AU$-779.73K (operating CF AU$-779.73K minus capex AU$0.00) represents -4% of total liabilities (AU$176.49K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of INVEX Therapeutics Ltd (2019–2025)
Financial flexibility index of INVEX Therapeutics Ltd from 2019 to 2025. Historical Financial Flexibility Index trend for INVEX Therapeutics Ltd across 7 annual periods. Check INVEX Therapeutics Ltd (IXC) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
INVEX Therapeutics Ltd Financial Flexibility Index by Year (2019–2025)
INVEX Therapeutics Ltd financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for INVEX Therapeutics Ltd. For the full cash flow conversion analysis, see INVEX Therapeutics Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.96x | AU$-652.57K | AU$-652.57K | AU$220.59K | ▲ +47.8% |
| 2024 | -5.66x | AU$-2.44 Million | AU$-2.44 Million | AU$431.63K | ▼ -29.6% |
| 2023 | -4.37x | AU$-6.87 Million | AU$-6.87 Million | AU$1.57 Million | ▼ -29.9% |
| 2022 | -3.36x | AU$-3.38 Million | AU$-3.38 Million | AU$1.00 Million | ▼ -32.0% |
| 2021 | -2.55x | AU$-1.68 Million | AU$-1.68 Million | AU$658.61K | ▼ -220.3% |
| 2020 | -0.80x | AU$-1.60 Million | AU$-1.60 Million | AU$2.02 Million | ▼ -235.3% |
| 2019 | -0.24x | AU$-221.94K | AU$-230.13K | AU$935.49K | — |